During the past decade, Dr Charles Farthing conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Dr Charles Farthing" are "HIV Infections" (2 trials). Many other conditions were trialed in "Dr Charles Farthing" in a lesser frequency.

Most popular intervention types in "Dr Charles Farthing" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Delavirdine mesylate" (2 trials), "Nelfinavir mesylate" (2 trials), "Ritonavir" (2 trials), "Saquinavir" (2 trials) and "Lamivudine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Dr Charles Farthing" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Dr Charles Farthing". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Dr Charles Farthing, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Dr Charles Farthing, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".